Kallikrein 10 antibody - Catalytic domain (ab40956)

Product Name 

Kallikrein 10 antibody - Catalytic domain

Product type 

Primary antibodies

Description 

Rabbit polyclonal to Kallikrein 10 - Catalytic domain

Immunogen 

Synthetic peptide based on the catalytic domain of Human Kallikrein 10.

(Peptide available as ab43092.)

Reacts with 
(species key)

Hu

Specificity 

Ab40956 reacts with human Kallikrein 10 and does not react with the other human kallikreins (hK1-9, 11-15).

We have a range of domain specific antibodies for this target. For a full list please see all Kallikrein 10 antibodies

Tested applications 
(see key)

WB

Abreviews 

Customer reviews (see key)

Read about Abreviews

Application notes 
(see key)

Recommended dilutions
WB: 1/1000 (when using colorimetric substrates such as BCIP/NBT) - 1/5000 (for chemiluminescent substrates). Predicted molecular weight: 30 kDa. The full length Kallikrein 10 sequence codes for a protein of 276 amino acids, with predicted mass of 30.1 kDa. A range of different sized bands can be seen for Kallikrein 10 in different tissues and in cell culture media, ranging from 16-34 kDa, probably representing different proteolytically processed forms. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Cellular localization 

Secreted

Research areas 

Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> Kallikreins
Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> Kallikreins
Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> Kallikreins

Relevance 

Kallikrein 10, also known as normal epithelial cell specific-1 (NES1) and protease serine-like 1 (PRSSL1), is a trypsin-like serine proteinase. Originally described from a subtractive library looking for genes that were down-regulated in breast cancer, kallikrein 10 was thought to be epithelial cell specific. Kallikrein 10 is reported to be up regulated in pancreatic cancer and ovarian cancer, but down regulated in testicular cancer and breast cancer, perhaps due to differential hormonal regulation, or tissue specificities. Breast cancer patients that had elevated kallikrein 10 had a worse prognosis, leading to speculation that kallikrein 10 might be protective in breast cancer, similar to the argument put forth for kallikrein 3 in prostate cancer. Kallikrein 10 is found in high levels in the pancreas and in lower levels in the tonsils, esophagus, skin, brain, testis and ovary. Biological fluids (breast milk, serum, seminal plasma, urine) contain kallikrein 10, the highest levels found in milk. The cerebral spinal fluid (CSF) contains Kallikrein 10, and was reported to be elevated in patients with Alzheimer’s disease. Endogenous inhibitors include kallistatin, protein-C inhibitor and 1-proteinase inhibitor, although Kallikrein 10 can be found complexed to a number of different proteinase inhibitors.

Database links 

Raised in 

Rabbit

Clonality 

Polyclonal

Isotype 

IgG

Purity 

Immunogen affinity purified

Storage buffer 

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol

Material safety datasheets (MSDS) for this product:
Glycerol MSDS
Sodium Azide MSDS

Form 

Liquid

Concentration 

1.000 mg/ml

Storage instructions 

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

See below for Kallikrein 10 antibody - Catalytic domain images, references, products related to ab40956 and other tools.

Kallikrein 10 antibody - Catalytic domain images:

Customer reviews (feedback) regarding Kallikrein 10 antibody - Catalytic domain

Customer FAQs regarding Kallikrein 10 antibody - Catalytic domain

Protocols for Kallikrein 10 antibody - Catalytic domain

Price and availability of products related to Kallikrein 10 antibody - Catalytic domain

Kallikrein 10 antibody - Catalytic domain - related products: